Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
International Journal of Molecular Sciences · 14.11.2023 · 24 (22) · 16316
DOI: 10.3390/ijms242216316 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.11.2023. Verfasst von Hasan Slika und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 347 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khatib Brain Tumor Center.
Abstract (Originalsprache)
Glioblastoma is the most common malignant primary central nervous system tumor and one of the most debilitating cancers. The prognosis of patients with glioblastoma remains poor, and the management of this tumor, both in its primary and recurrent forms, remains suboptimal. Despite the tremendous efforts that are being put forward by the research community to discover novel efficacious therapeutic agents and modalities, no major paradigm shifts have been established in the field in the last decade. However, this does not mirror the abundance of relevant findings and discoveries made in preclinical glioblastoma research. Hence, developing and utilizing appropriate preclinical models that faithfully recapitulate the characteristics and behavior of human glioblastoma is of utmost importance. Herein, we offer a holistic picture of the evolution of preclinical models of glioblastoma. We further elaborate on the commonly used in vitro and vivo models, delving into their development, favorable characteristics, shortcomings, and areas of potential improvement, which aids researchers in designing future experiments and utilizing the most suitable models. Additionally, this review explores progress in the fields of humanized and immunotolerant mouse models, genetically engineered animal models, 3D in vitro models, and microfluidics and highlights promising avenues for the future of preclinical glioblastoma research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Faculty of Medicine, Ege University, 35100 Izmir, Turkey.
- School of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy.
- Faculty of Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
- Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA.
ORCID-Profile: Hasan Slika, Ziya Karimov, Tatiana Abou-Mrad, Safwan Alomari, Betty Tyler
Förderung
- Khatib Brain Tumor Center
Zitieren
APA
Slika, H., Karimov, Z., Alimonti, P., Abou-Mrad, T., De Fazio, E., Alomari, S., & Tyler, B. (2023). Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues. International Journal of Molecular Sciences, 24(22), 16316. https://doi.org/10.3390/ijms242216316
Vancouver
Slika H, Karimov Z, Alimonti P, Abou-Mrad T, De Fazio E, Alomari S, et al. Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues. International Journal of Molecular Sciences. 2023;24(22):16316. doi:10.3390/ijms242216316
BibTeX
@article{Slika2023,
author = {Slika, Hasan and Karimov, Ziya and Alimonti, Paolo and Abou-Mrad, Tatiana and De Fazio, Emerson and Alomari, Safwan and Tyler, Betty},
title = {Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {22},
pages = {16316},
doi = {10.3390/ijms242216316}
}
EUVIMED